These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1779227)

  • 1. The effect of some platinum compounds on the activity of the CTP synthetase of Ehrlich ascites tumor cells: in vitro and in vivo studies.
    Ganeva RL; Spassovska NC; Genchev DD
    J Inorg Biochem; 1991 Sep; 43(4):717-22. PubMed ID: 1779227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cis-diamminedichloroplatinum(II) and other platinum compounds on the RNA polymerase reaction.
    Ganeva R; Spassovska N; Genchev D
    Cytobios; 1994; 77(309):81-6. PubMed ID: 8020247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of some platinum compounds on the biosynthesis of RNA and its precursors.
    Ganeva RL; Spassovska NC; Genchev DD
    J Inorg Biochem; 1990 Sep; 40(1):13-8. PubMed ID: 1704415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of GTP in CTP synthetase from Ehrlich ascites tumor cells.
    Kizaki H; Ohsaka F; Sakurada T
    Biochem Biophys Res Commun; 1982 Sep; 108(1):286-91. PubMed ID: 7150287
    [No Abstract]   [Full Text] [Related]  

  • 5. CTP synthetase from Ehrlich ascites tumor cells. Subunit stoichiometry and regulation of activity.
    Kizaki H; Ohsaka F; Sakurada T
    Biochim Biophys Acta; 1985 May; 829(1):34-43. PubMed ID: 3995044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of N4-substituted CTP by mammalian CTP synthetase.
    Kizaki H; Ohsaka F; Sakurada T
    Biochem Biophys Res Commun; 1987 May; 145(1):569-74. PubMed ID: 3593352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies with GMP synthetase from Ehrlich ascites cells. Purification, properties, and interactions with nucleotide analogs.
    Spector T
    J Biol Chem; 1975 Sep; 250(18):7372-6. PubMed ID: 240826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of CTP synthetase from Ehrlich ascites tumor cells.
    Kizaki H; Sakurada T; Weber G
    Biochim Biophys Acta; 1981 Nov; 662(1):48-54. PubMed ID: 7306558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors.
    Frühauf S; Zeller WJ
    Cancer Chemother Pharmacol; 1991; 27(4):301-7. PubMed ID: 1998986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effects of cis-dichlorodiammine platinum (II) on tumor progression and programmed death of Ehrlich ascites carcinoma cells.
    Razin BV; Inzhevatkin EV; Nefedova VV; Egorova AB; Kazbanov VI; Nefedov VP
    Bull Exp Biol Med; 2001 Jun; 131(6):568-9. PubMed ID: 11586409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the phosphoribosyl-formylglycineamidine synthetase of Ehrlich ascites tumor cells by glutamine analogues.
    Chu SY; Henderson JF
    Biochem Pharmacol; 1972 Feb; 21(3):401-6. PubMed ID: 5062595
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlamydia trachomatis CTP synthetase: molecular characterization and developmental regulation of expression.
    Wylie JL; Berry JD; McClarty G
    Mol Microbiol; 1996 Nov; 22(4):631-42. PubMed ID: 8951811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GMP synthetase from Ehrlich ascites cells.
    Spector T
    Methods Enzymol; 1978; 51():219-24. PubMed ID: 211375
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC; Borch RF
    Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.
    Köpf-Maier P; Wagner W; Liss E
    J Cancer Res Clin Oncol; 1983; 106(1):44-52. PubMed ID: 6684118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
    Roberts JJ; Friedlos F
    Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of adenylosuccinate synthetase and adenylosuccinate lyase from Ehrlich ascites-tumour cells by 6-thioinosine 5'-phosphate.
    Atkinson MR; Morton RK; Murray AW
    Biochem J; 1964 Aug; 92(2):398-404. PubMed ID: 5891253
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L
    Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo.
    Howle JA; Gale GR
    Biochem Pharmacol; 1970 Oct; 19(10):2757-62. PubMed ID: 5478584
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo changes of heterogeneity of mouse peritoneal macrophages induced by cis-diamminedichloroplatinum (II) (cis-DDP) and related platinum compounds.
    Peschke T; Schröer HP; Augsten K
    Exp Toxicol Pathol; 1992 Jun; 44(3):154-9. PubMed ID: 1504581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.